HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
654,74
USD
+7,30
USD
+1,13
%
NAV
Werbung
Top Holdings
Chart
Tabelle
| Name | ISIN | Anteil |
|---|---|---|
| United Therapeutics Corp | US91307C1027 | 5,25% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,94% |
| Gilead Sciences Inc | US3755581036 | 4,63% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,28% |
| BridgeBio Pharma Inc | US10806X1028 | 4,11% |
| Ascendis Pharma AS ADR | US04351P1012 | 4,05% |
| argenx SE ADR | US04016X1019 | 4,04% |
| Amgen Inc | US0311621009 | 3,89% |
| Axsome Therapeutics Inc | US05464T1043 | 3,74% |
| Insmed Inc | US4576693075 | 3,62% |
| Sonstige | 57,44% |
